Associated Papers
Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions.
Yoo JM et al.
Frontiers in Molecular Biosciences, 2022
Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria.
Tsuboi Y et al.
Journal of Movement Disorders, 2021
Effects of Mutations on the Reconfiguration Rate of α-Synuclein.
Acharya S et al.
The Journal of Physical Chemistry. B, 2015
O-GlcNAc modification prevents peptide-dependent acceleration of α-synuclein aggregation.
Marotta NP et al.
Chembiochem : a European Journal of Chemical Biology, 2012
A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation.
Waxman EA et al.
Journal of Neurochemistry, 2010
beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
Kim YS et al.
Biochemical and Biophysical Research Communications, 2009
Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
Koo HJ et al.
Biochemical and Biophysical Research Communications, 2009
Sequence determinants regulating fibrillation of human alpha-synuclein.
Koo HJ et al.
Biochemical and Biophysical Research Communications, 2008
Select a paper to view details